Joint Program in Nuclear Medicine
Bone Marrow Scintigraphy
Chandra Dass, MD
J. Anthony Parker, MD PhD
February 11, 1997
Presentation
A 65 year old male with non-Hodgkin lymphoma, in relapse after bone marrow
transplant, was admitted with acute respiratory distress. Routine blood
workup showed thrombocytopenia, which continued to drop even after repeated
plasmapheresis. Peripheral smear showed normal white count and normal reticulocyte
count and no evidence of microangiopathic changes. A bone marrow aspirate
from the iliac crest demonstrated a completely aplastic marrow with no
hemopoietic cells. A repeat marrow aspirate from the other iliac crest
revealed the same findings. The patient was referred for a Tc-99m sulfur
colloid bone marrow scan.
Imaging Findings
Since the bone marrow findings were incompatible with the peripheral blood
picture, a sampling error was suspected. The bone marrow
scan showed absent marrow in both iliac region. The region of absent
activity was rectangular in appearance and was
due to prior radiation therapy unknown at the time of biopsy. A repeat
biopsy from the sternum was successful and revealed marked erythroid hyperplasia,
normal granulocyte maturation and megakaryocyte hypoplasia.
Discussion
During fetal growth, hematopoiesis takes place in all bony cavities (axial
and appendicular skeleton) as well as in liver and spleen. Prior to birth,
splenic and hepatic hematopoiesis disappear, and gradually thereafter hematopoietic
tissue (red marrow) is replaced by fat (yellow marrow) beginning in the
distal bones and retracting to the adult pattern by age ten. In the adult,
hematopoietic marrow is confined to the axial skeleton and proximal portions
of the humerus and femur. Bone marrow weighs approximately 3000 g in normal
adult man. The red and yellow marrow each constitute half of the bone marrow
weight. However 50% of red marrow is adipose tissue. Therefore, about 75%
of total marrow in adults is adipose tissue.
The three major tissue that constitute the red marrow include
-
the hematopoietic (erythropoietic and myelopoietic) cells;
-
the reticuloendothelial cells; and
-
the trabecular framework, that supports both cell types.
The reticuloendothelial cells and the hematopoietic cells provide functional
mechanisms for radiopharmaceutical localization in bone marrow scintigraphy.
Radiotracers:
The radiotracers used for bone marrow scintigraphy can be divided according
to the target cell type into
-
reticulo- endothelial imaging (Tc-99m-sulfur colloid; Tc-99m-nanocolloid);
-
Tc-99m-HMPAO-WBC;
-
erythropoietic imaging (Fe-52 citrate);
-
myelopoietic or granulopoietic imaging (Tc-99m-non-specific Ab);
-
unclear mechanism (In-111-Cl).
Fe-52 citrate is physiologically the ideal agent for the assessment of
erythropoietic marrow activity. Unfortunately, it is relatively expensive
(cyclotron produced) and suboptimal for imaging with the currently widely
available gamma cameras (positron emission). However, lack of activity
in the liver & spleen allows evaluation of extramedullary hematopoiesis
in the above organs and detection of abnormalities in the thoracolumbar
spine.
At present, Tc-99m sulfur colloid is the colloid agent most commonly
used in the United States. Because of the smaller particle size, sulfur
colloid prepared by hydrogen sulphide bubbling technique (< 100 nm)
yields better marrow images than prepared by acid reduction of sodium thiosulfate
(100-1000 nm). Nanocolloids (Tc-99m-microaggregated human serum albumin;
Tc-99m-antimony sulphide colloid) are mainly used in Europe (<80 nm).
Except in a few predictable clinical situations (pure red cell aplasia;
acute radiation injury; myelosuppressive chemotherapy; treated polycythemia
vera; myelofibrosis), scans with Fe-52 and Tc-99m-sulfur colloid show identical
marrow distribution pattern, thus allowing the latter to be used as a practical
alternative to the former. On the other hand, normal liver and splenic
uptake makes colloid technique useless in evaluating extramedullary hematopoiesis
in these organs and detection of abnormalities in the adjacent thoracolumbar
spine.
Though In-111 binds to transferrin in exactly the same manner as iron,
the biological behavior of indium and iron is different (In-3+ is not reduced
like iron to In-2+ state) in as many respects as they are similar, and
marrow In-111 uptake can only be extrapolated to the distribution of erythropoietic
marrow with great care. The mechanism of marrow uptake is not yet clear,
though in patients with normal bone marrow the distribution is similar
to that of Tc-99m-sulfur colloid. Many investigators believe that In-111
is essentially an reticuloendothelial cell agent.
Tc-99m HMPAO-white blood cells appears to be a good bone marrow imaging
tracer. Because granulocytes are normally disposed of in the marrow, the
images presumably represent the distribution of marrow reticuloendothelial
cells. Although there is considerable liver activity, it is significantly
less than the colloid agents, so that the spine is not usually obscured.
Labor-intensive labeling procedure makes this technique unpopular. Immunoscintigraphy
of the bone marrow has been carried out with Tc-99m labeled murine monoclonal
antibody (Tc-99m-NSAb) directed against nonspecific cross-reacting antigen-95,
expressed in the cytoplasm and at the cell membrane of granulocytes in
the blood as well as in mature granulopoietic cells in the bone marrow.
Granulopoietic bone marrow cells are in 50 to 100 : 1 excess compared with
granulocytes in the peripheral blood. Therefore Tc-99m-NSAb distribute
primarily to granulopoietic bone marrow following IV injection providing
high quality images. However, increasing hepatic and splenic uptake has
been reported after repeated injections of murine monoclonal antibody.
Evaluation:
Bone marrow scans are evaluated for the presence or absence of activity
in the central marrow, for peripheral extension, and for any focal defects
for comparison with white blood cell scans. When erythropoiesis is stimulated,
the first response is hypertrophy of the erythroid marrow at the expense
of fat in the marrow cavity. This occurs in areas of skeleton that normally
contain active marrow. Since the distribution of marrow is normal, scintigraphy
cannot detect these early changes. When further expansion of marrow tissue
is needed, the marrow space moves peripherally into the long bones and
can even involve the small bones of the hands and feet. The expansion is
usually centrifugal and symmetrical, but occasionally occurs in an asymmetrical
and irregular manner that can cause a patchy appearance on the bone marrow
scintigraphy. In reticuloendothelial cells scans, the liver and spleen
are evaluated for size and presence of any defects, while in radioiron
scans, evidence of significant splenic uptake would indicate extramedullary
hematopoiesis.
Comparison with other Techniques:
The other techniques available for the evaluation of bone marrow are bone
marrow aspiration biopsy and MRI. Bone marrow biopsy is an excellent techniques
for evaluating bone marrow and provides a specific clinical diagnosis.
Since biopsy is limited to a small part of the total blood-forming organ,
it is prone for sampling errors. Radionuclide bone marrow imaging is a
simple noninvasive technique that provides information about the whole
body distribution of functioning bone marrow in various clinical states
(hematological, malignant and post chemotherapy & radiotherapy) and
also aids in the differential diagnosis of osteomyelitis (infection versus
normal marrow). Magnetic resonance imaging is a highly sensitive technique
for imaging of normal and abnormal marrow and can predict differences between
fatty, cellular, fibrotic, and hemosiderotic marrow. However bone marrow
scintigraphy is preferred when whole body screening is desired, since the
cost of MRI limits its use for this purpose.
References
1. Silberstein B: Nuclear Hematology: The Erythron. In: Nucl Med Annual.
198: Pp 163-174.
2. Datz F, Tayler A: The clinical use of radionuclide bone marrow imaging.
Semin Nucl Med, Vol XV, No 3 (July), 1985: 239-257.
3. Kim C, Reske S.N, Abass Alavi: Bone marrow scintigraphy. In: Nuclear
Medicine. Robert Henkin, et al (eds) 1996 by Mosby-Year book. Pp 1223-124.
4. Nuclear Medicine Diagnosis and therapy. Herbert CJ, et al (eds) 1996
by Thieme medical Publishers, Inc. New York, NY. Pp 780-784.
Click here to go to Joint
Program in Nuclear Medicine home page and Copyright notice.
J. Anthony Parker, MD PhD, Tony_Parker@bidmc.harvard.edu